The Impact of Proton Pump Inhibitors on the Fecal Microbiome
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesis is that daily use of a proton pump inhibitor (PPI) is associated
with significant alterations in the healthy fecal microbiome that are similar to those seen
in persons with an initial episode of clostridium difficile infection (CDI).